Long-lasting hypotensive effect in renal hypertensive rats induced by nitric oxide released from a ruthenium complex

Journal of Cardiovascular Pharmacology

Volumn 60, Issue 2, 2012, Pages 193-198

  Rodrigues, Gerson J ^a   Pereira, Amanda C ^a   Vercesi, Juliana A ^a   Lima, Renata G ^a   Silva, Roberto S ^a   Bendhack, Lusiane M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

hypotensive effect; nitric oxide donor; NO synthase; renal hypertension; superoxide scavenger

Indexed keywords

ANTIHYPERTENSIVE AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; RUTHENIUM COMPLEX; TEMPOL; TERPY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; RENOVASCULAR HYPERTENSION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; CYCLIC N-OXIDES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HYPERTENSION, RENOVASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; RATS; RUTHENIUM COMPOUNDS; SPIN LABELS; TIME FACTORS;

EID: 84865582356     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31825bacc4     Document Type: Article

References (30)

1. Umans JG, Levi R. Nitric oxide in the regulation of blood flow and arterial pressure. Annu Rev Physiol. 1995;57:771-790.
2. Rapoport RM, Draznin MB, Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature. 1983;306:174-176.
3. Yetik-Anacak G, Catravas JD. Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol. 2006;45:268-276.
4. Mclntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: the role of superoxide anion. Hypertension. 1999;34: 539-545.
5. ClozelKuhn H, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532-540.
6. Feelisch M. Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur Heart J. 1993;14(suppl 1): 123-132.
7. Laursen JB, Mulsch A, Boesgaard S, et al. In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide. Circulation. 1996;94:2241-2247.
8. Munzel T, Sayegh H, Freeman BA, et al. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest. 1995;95: 187-194.
9. Arnold WP, Longnecker DE, Epstein RM. Photodegradation of sodium nitroprusside: biologic activity and cyanide release. Anesthesiology. 1984;61:254-260.
10. Bonaventura D, Oliveira FS, Togniolo V, et al. A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation. Nitric Oxide. 2004;10:83-91.
11. Ferezin CZ, Oliveira FS, da Silva RS, et al. The complex trans-[RuCl ([15]aneN4NO]2+ induces rat aorta relaxation by ultraviolet light irradiation. Nitric Oxide. 2005;13:170-175.
12. De Lima RG, Sauaia M, Bonaventura D, et al. Influence of ancillary ligand L in the nitric oxide photorelease by the [Ru(L)(terpy)NO]3+ complex and its vasodilator activity based on visible light irradiation. Inorg Chim Acta. 2006;359:2543-2549.
13. Lunardi CN, Vercesi JA, da Silva RS, et al. Vasorelaxation induced by the new nitric oxide donor cis-[Ru(Cl)(bpy)(2)(NO)](PF(6)) is due to activation of K(Ca) by a cGMP-dependent pathway. Vascul Pharmacol. 2007;47:139-144.
14. Da Silva RS, Marchesi MS, Khin C, et al. Photoinduced electron transfer between the cationic complexes Ru(NH3)(5)pz(2+) and trans-RuCl ([15]aneN(4))NO2+ mediated by phosphate ion: Visible light generation of nitric oxide for biological targets. J Phys Chem B. 2007;111: 6962-6968.
15. Sauaia MG, de Lima RG, Tedesco AC, et al. Photoinduced NO release by visible light irradiation from pyrazine-bridged nitrosyl ruthenium complexes. J Am Chem Soc. 2003;48:14718-14719.
16. Bonaventura D, De Lima RG, Vercesi JA, et al. Comparison of the mechanism underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex. Vascul Pharmacol. 2007;46:215-222.
17. Rodrigues GJ, Lunardi CN, de Lima RG, et al. Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats. Nitric Oxide. 2008;18:176-183.
18. Rodrigues GJ, Restini CB, Lunardi CN, et al. Caveolae dysfunction contributes to impaired relaxation induced by nitric oxide donor in aorta from renal hypertensive rats. J Pharmacol Exp Ther. 2007;23: 831-837.
19. Gollke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349-355.
20. Cuzzocrea S, McDonald MC, Mazzon E, et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of splancnic artery occlusion and reperfusion. Shock. 2000;4: 150-156.
21. Munhoz FC, Potje SR, Pereira AC, et al. Hypotensive and vasorelaxing effects of the new NO-donor [Ru(terpy)(bdq)NO+]3+ in spontaneously hypertensive rats. Nitric Oxide. 2012;26:111-117.
22. Barros BF, Toledo JC, Franco DW, et al. A new inorganic vasodilator, trans-[Ru(NO)NH3)4(POET)3](PF6)3: hypotensive effect of endothelium- dependent and -independent vasodilators in different hypertensive animals models. Nitric Oxide. 2002;7:50-56.
23. De Gaitani CM, de Melo MC, Lunardi CN, et al. Hypotensive effect of the nitrosyl ruthenium complex nitric oxide donor in renal hypertensive rats. Nitric Oxide. 2009;20:195-199.
24. Stambury DM, Mulac WA, Sullivan JC, et al. Superoxide reactions with (isonicotinamide)pentaammineruthenium(II) and -(III). Inorg Chem. 1980;19:3735.
25. Fukui T, Ishizaka N, Rajagopalan S, et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45-51.
26. Heitzer T, Wenzel U, Hink U, et al. Increased NAD(P)H oxidasemediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 1999;55: 252-260.
27. Hamilton CA, Brosnan MJ, McIntyre M, et al. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 2001;37:529-534
28. Torsoni AS, de Barros BF, Toledo JC Jr, et al. Hypotensive properties and acute toxicity of trans-[Ru(NH(3))(4)P(OEt)(3)(NO)](PF(6))(3), a new nitric oxide donor. Nitric Oxide. 2002;6:247-254.
29. Zanichelli PG, Estrela HF, Spadari-Bratfisch RC, et al. The effects of ruthenium tetraammine compounds on vascular smooth muscle. Nitric Oxide. 2007;16:189-196.
30. Ishibashi T, Miwa T, Nishizawa N, et al. Role of plasma S-nitrosothiols in regulation of blood pressure in anesthetized rabbits with special references to hypotensive effects of acetylcholine and nitrovasodilators. Biol Pharm Bull. 2011;34:1307-1312.